The development and clinical application of inhibitors that target the epidermal growth factor
receptor (EGFR) provide important insights for new lung cancer therapies, as well as for the …

… Activating mutations in the epidermal growth factor receptor gene (EGFR) confer …
EGFR mutations in such patients and analyzed the association between the mutations and …

… therapeutics, the discovery of mutations in epidermal growth factor receptor (EGFR) in 15–20…
responses despite presence of activating EGFR mutations. epidermal growth factor receptor …

… entities, are caused by mutations in one of three fibroblast growth factor receptor genes (FGFR1,
FGFR2, and FGFR3). The present review list all mutations described to date in these …

… Several types of epidermal growth factor receptor (EGFR)gene mutations have been …
diversity of EGFR mutations in glioblastomas and to determine whether gene mutation is inevitably …

… growth factor receptor (EGFR) mutations are prevalent in female nonsmokers. However,
EGFR mutations … In this study, we first examined a large series of SCLCs to address mutation …

… agents targeting the epidermal growth factor receptor (EGFR) … , and frequent mutations
involving either the receptor itself or … The epidermal growth factor receptor (EGFR), a member of …

… Summary of epidermal growth factor receptor (EGFR) mutations. The different domains of …
and frequencies of the different EGFR mutations. The shown mutations are those identified in …

… The discovery of the epidermal growth factor receptor (EGFR) and development of targeted
… EGFR belongs to the HER/ErbB family of growth factor receptors. These receptors consist of …

… since mutations of the tyrosine kinase domain of the epidermal growth factor receptor (EGFR…
insight into the biological impact of EGFR mutations in cell culture experiments and in …